During the reporting period we recruited our first cohort of EDUC2-supported CIRM Bridges students and developed our graduate program infrastructure. Our first cohort began the program in August 2022. All students successfully identified host internship labs at UC Davis and are in the process of developing their project proposals with their research advisors. Their research internships will begin June 1, 2023, following their advancement to candidacy seminars. We hosted a Regenerative Medicine Lecture (RML) seminar in the Fall, a stem cell research focused seminar that is advertised and open to the public. Our RML speaker in the Fall was Dr. Gene Yeo, Professor of Cellular and Molecular Medicine from the University of California, San Diego, who presented a lecture titled “RNA, No Longer the Humble Cousin of DNA,” in which he shared research on RNA binding proteins and how defects in these proteins can lead to a diversity of diseases, including cancer and neurological diseases like Amyotrophic Lateral Sclerosis (ALS). We also recruited five speakers for a new Spring semester seminar series called the Bench to Bedside (B2B) colloquium, which was developed to provide our students with a more comprehensive understanding of regenerative medicine. To achieve this goal, the B2B seminars will feature diverse speakers with a variety of experiences and expertise in the field, including research scientists from the biotech sector who are working on developing novel therapeutics, clinical scientists who administer regenerative medicine treatments, and patient advocates who can speak to the experience of patients, including issues related to equity, inclusion, and cultural competencies.